In the era of antiviral trials for MS, the answer lies in the details

Mult Scler Relat Disord. 2024 Feb:82:105444. doi: 10.1016/j.msard.2024.105444. Epub 2024 Jan 12.
No abstract available

Keywords: Antivirals; Epstein-Barr virus; Multiple sclerosis; Tenofovir.

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use
  • Epstein-Barr Virus Infections*
  • Epstein-Barr Virus Nuclear Antigens
  • Herpesvirus 4, Human
  • Humans
  • Multiple Sclerosis* / drug therapy

Substances

  • Antiviral Agents
  • Epstein-Barr Virus Nuclear Antigens

Associated data

  • ClinicalTrials.gov/NCT03283826